Bicycle Therapeutics PLC (BCYC)
22.18
-0.18
(-0.80%)
USD |
NASDAQ |
May 16, 16:00
22.16
-0.02
(-0.11%)
After-Hours: 20:00
Bicycle Therapeutics Total Return Price: 22.18 for May 16, 2024
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| May 16, 2024 | 22.18 |
| May 15, 2024 | 22.36 |
| May 14, 2024 | 21.85 |
| May 13, 2024 | 22.57 |
| May 10, 2024 | 22.89 |
| May 09, 2024 | 23.58 |
| May 08, 2024 | 23.62 |
| May 07, 2024 | 23.08 |
| May 06, 2024 | 23.30 |
| May 03, 2024 | 24.58 |
| May 02, 2024 | 24.69 |
| May 01, 2024 | 24.20 |
| April 30, 2024 | 23.45 |
| April 29, 2024 | 23.41 |
| April 26, 2024 | 22.73 |
| April 25, 2024 | 22.52 |
| April 24, 2024 | 22.67 |
| April 23, 2024 | 22.68 |
| April 22, 2024 | 22.57 |
| April 19, 2024 | 23.45 |
| April 18, 2024 | 24.49 |
| April 17, 2024 | 21.82 |
| April 16, 2024 | 21.93 |
| April 15, 2024 | 21.82 |
| April 12, 2024 | 22.30 |
| Date | Value |
|---|---|
| April 11, 2024 | 22.50 |
| April 10, 2024 | 22.99 |
| April 09, 2024 | 23.07 |
| April 08, 2024 | 22.96 |
| April 05, 2024 | 22.73 |
| April 04, 2024 | 22.61 |
| April 03, 2024 | 23.32 |
| April 02, 2024 | 23.73 |
| April 01, 2024 | 24.25 |
| March 28, 2024 | 24.90 |
| March 27, 2024 | 24.55 |
| March 26, 2024 | 24.53 |
| March 25, 2024 | 25.43 |
| March 22, 2024 | 25.49 |
| March 21, 2024 | 25.85 |
| March 20, 2024 | 25.61 |
| March 19, 2024 | 24.55 |
| March 18, 2024 | 24.12 |
| March 15, 2024 | 23.76 |
| March 14, 2024 | 22.94 |
| March 13, 2024 | 25.55 |
| March 12, 2024 | 25.04 |
| March 11, 2024 | 23.67 |
| March 08, 2024 | 25.35 |
| March 07, 2024 | 25.34 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
6.736
Minimum
Aug 28 2019
61.14
Maximum
Nov 15 2021
23.73
Average
21.82
Median
Apr 15 2024
Total Return Price Benchmarks
| Biodexa Pharmaceuticals Plc | 1.24 |
| NuCana PLC | 3.67 |
| TC BioPharm (Holdings) PLC | 1.14 |
| Adaptimmune Therapeutics PLC | 1.20 |
| Verona Pharma PLC | 13.36 |